Published in Cardiovascular Device Liability Week, November 6th, 2005
According to researchers in Italy, "In [our] study we randomly compared the estradiol-eluting stent (17-beta-E) with phosphorylcholine (PC)-coated stents in native coronary arteries."
F. Airoldi and colleagues of the San Raffaele Hospital in Milan reported, "The incidence of angiographic restenosis was 23% in the 17-beta-E group and 31% in the PC group (p=0.34). The major adverse cardiovascular event rates were also similar in the 2 groups (17% in the 17-beta-E group vs. 22% in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.